Literature DB >> 16134146

A novel functionally deficient MYH variant in individuals with colorectal adenomatous polyposis.

Pia Alhopuro1, Antony R Parker, Rainer Lehtonen, Susa Enholm, Heikki J Järvinen, Jukka-Pekka Mecklin, Auli Karhu, James R Eshleman, Lauri A Aaltonen.   

Abstract

Inherited biallelic mutations in the base excision repair gene MYH confer susceptibility to colorectal adenomas and carcinoma. Approximately 85% of Caucasians with MYH mutations carry the (c.494A>G) p.Y165C and (c.1145G>A) p.G382D variants. Only a few other clearly pathogenic mutations have been identified, and mutation analyses tend to focus on the two founder mutations rather than the whole coding region of the gene. We sequenced the entire coding region of MYH in a population-based series of 24 Finnish APC-mutation negative polyposis patients in order to identify novel pathogenic MYH variants. A population-based series of 1,042 Finnish colorectal cancer patients and 85 cancer-free controls were available for further evaluation. A functional cleavage assay was designed to evaluate consequences of possible novel variants to protein function. Three novel MYH variants, (c.270C>T) p.Y90Y, (c.1376C>A) p.A459D, and (c.1389G>C) p.T469T, were observed. p.A459D variant in exon 14 was identified in two patients from the polyposis series, once in homozygosity and once in compound heterozygosity with p.Y165C. In the population-based series of 1,042 colorectal cancer patients, the p.A459D mutation was identified once, in homozygosity (allele frequency 0.1%). No p.A459D mutations were identified in the control individuals. In vitro cleavage assay showed significantly reduced repair activity in p.A459D cells. Interestingly, another variant in the same codon has previously been described in a British study, supporting a key role for the codon 459 in MYH function. We therefore suggest that screening of mutations in MYH exon 14 should be added to the molecular analysis at-risk individuals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16134146     DOI: 10.1002/humu.9368

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  8 in total

Review 1.  Base-excision repair of oxidative DNA damage.

Authors:  Sheila S David; Valerie L O'Shea; Sucharita Kundu
Journal:  Nature       Date:  2007-06-21       Impact factor: 49.962

2.  Implication of MYH in colorectal polyposis.

Authors:  Jérémie H Lefevre; Christelle M Rodrigue; Najat Mourra; Malika Bennis; Jean-François Flejou; Rolland Parc; Emmanuel Tiret; Christian Gespach; Yann R Parc
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

Review 3.  Base excision repair and cancer.

Authors:  Susan S Wallace; Drew L Murphy; Joann B Sweasy
Journal:  Cancer Lett       Date:  2012-01-15       Impact factor: 8.679

Review 4.  Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer.

Authors:  Gulcin Tezcan; Berrin Tunca; Secil Ak; Gulsah Cecener; Unal Egeli
Journal:  World J Gastrointest Oncol       Date:  2016-01-15

5.  MUTYH-associated polyposis (MAP), the syndrome implicating base excision repair in inherited predisposition to colorectal tumors.

Authors:  Tiziana Venesio; Antonella Balsamo; Vito G D'Agostino; Guglielmina N Ranzani
Journal:  Front Oncol       Date:  2012-08-02       Impact factor: 6.244

6.  The role of MYH and microsatellite instability in the development of sporadic colorectal cancer.

Authors:  A Colebatch; M Hitchins; R Williams; A Meagher; N J Hawkins; R L Ward
Journal:  Br J Cancer       Date:  2006-10-10       Impact factor: 7.640

7.  MUTYH Associated Polyposis (MAP).

Authors:  M L M Poulsen; M L Bisgaard
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

8.  Understanding the role of the Q338H MUTYH variant in oxidative damage repair.

Authors:  Eleonora Turco; Ilenia Ventura; Anna Minoprio; Maria Teresa Russo; Paola Torreri; Paolo Degan; Sara Molatore; Guglielmina Nadia Ranzani; Margherita Bignami; Filomena Mazzei
Journal:  Nucleic Acids Res       Date:  2013-03-04       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.